Continuous inertial cavitation evokes massive ROS for reinforcing sonodynamic therapy and immunogenic cell death against breast carcinoma

Yifei Yin,Xingwu Jiang,Liping Sun,Hongyan Li,Chunxia Su,Yan Zhang,Guang Xu,Xiaolong Li,Chongke Zhao,Yu Chen,Huixiong Xu,Kun Zhang
DOI: https://doi.org/10.1016/j.nantod.2020.101009
IF: 17.4
2021-02-01
Nano Today
Abstract:<p>Intratumoral immunosuppressive microenvironment (ISM) remains the dominant limitation to disable oncological immunotherapy such as immunogenic cell death (ICD). To resolve the immune escape, a sonodynamic therapy (SDT)-based nanoplatform featuring continuous CO<sub>2</sub> bubbling has been engineered to enforce continuous ultrasound-triggered inertial cavitation (UIC) for augmenting ROS production. Systematic <em>in vitro</em> and <em>in vivo</em> results demonstrate that the continuous UIC expedites massive production of reactive oxygen species (ROS), consequently enabling multiple enhancements of SDT under only one administration. More significantly, the highly-accumulative ROS arising from continuous UIC have been demonstrated to induce robust ICD that is typically represented by more antigen exposure and presentation, augmented DCs maturation and more activated effector CD8<sup>+</sup> T cells infiltration <em>in vitro</em> &amp; <em>in vivo</em>. Concurrently, the most ISM alleviation <em>via</em> releasing more pro-inflammatory cytokines and facilitating pro-tumorigenic M2-like macrophage polarization into anti-tumorigenic M1-like counterparts is accompanied, enabling immune escape blockade. Contributed by the significant ISM alleviation and massive ROS production for enhancing SDT and ICD, such SDT-based composite nanoplatforms harvest the most substantially enhanced inhibitory consequences against primary and metastatic tumors, which, thus, provide a profound attribute for T cell-based immunotherapy against tumor.</p>
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?
### Problems the Papers Try to Solve #### The First Paper **Background and Objectives** - **Research Background**: Active ulcerative colitis (UC) leads to an immature, IgG - predominant plasmablast/plasma cell (PB/PC) response in the inflamed intestinal tissues, and an increased frequency of plasma cells in the circulation that home to the intestine. These changes are related to disease activity and complications and may be used to monitor the disease process. - **Research Objective**: To explore the characteristics of immune cell responses in the inflamed intestinal tissues of UC patients and their relationships with disease activity and complications, to provide new insights into the pathological mechanism of UC, and to have an important impact on the application of existing and emerging therapeutic drugs. #### The Second Paper **Background and Objectives** - **Research Background**: Genome - wide association studies (GWAS) have identified more than 250 risk loci associated with Crohn's disease (CD) and ulcerative colitis (UC), but these known loci can only explain a small fraction of heritability. Therefore, further research is needed to discover more unrecognized IBD genetic associations. - **Research Objective**: To identify new IBD genetic susceptibility loci by conducting the largest - scale meta - GWAS analysis to date, to further expand the understanding of the genetic basis of IBD, and to explore the potential shared genetic architecture between IBD and other diseases. #### The Third Paper **Background and Objectives** - **Research Background**: Paneth cells (PC) in the small intestine play a crucial role in regulating host - microbe homeostasis. PC functional defects in IBD patients, especially in autophagy and host defense pathways, are associated with intestinal inflammation. TL1A (TNFSF15) is associated with IBD susceptibility and severity in GWAS, and its expression is increased in IBD patients, especially in those carrying TL1A risk alleles. Mouse models with TL1A overexpression show that PC hyperplasia and morphological abnormalities precede the development of spontaneous ileitis and are dependent on the gut microbiota. - **Research Objective**: To determine how TL1A alters the biological properties of PC and its impact on the gut microbiota and metabolites, thereby promoting the occurrence of ileal inflammation. ### Summary These three papers respectively explore the pathological mechanisms and genetic basis of IBD (especially UC and CD) from different perspectives. The first paper focuses on the characteristics of immune cell responses in UC patients; the second paper looks for new IBD genetic susceptibility loci through large - scale meta - GWAS analysis; the third paper explores the impact of TL1A overexpression on Paneth cells in the small intestine and the gut microbiota. These studies together provide important scientific basis for the diagnosis, treatment and prevention of IBD.